Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Etelcalcetide
Drug ID BADD_D02514
Description Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
Indications and Usage Etelcalcetide is a calcium-sensing receptor agonist indicated for: Secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
Marketing Status Not Available
ATC Code H05BX04
DrugBank ID DB12865
KEGG ID D10676
MeSH ID C583569
PubChem ID 71511839
TTD Drug ID D07RYI
NDC Product Code 55513-740; 55463-0030; 52076-6227; 55513-742; 55513-741
Synonyms etelcalcetide hydrochloride | velcalcetide | etelcalcetide | KAI-4169 | Parsabiv | AMG-416 | AMG 416
Chemical Information
Molecular Formula C38H73N21O10S2
CAS Registry Number 1262780-97-1
SMILES CC(C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN= C(N)N)NC(=O)C(C)NC(=O)C(CSSCC(C(=O)O)N)NC(=O)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Upper gastrointestinal haemorrhage24.07.02.024; 07.12.02.0060.004819%
Ventricular fibrillation02.03.04.0080.001257%
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.0030.086741%
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Peripheral swelling08.01.03.053; 02.05.04.015--Not Available
Blood phosphorus decreased13.11.01.0150.028914%Not Available
Blood phosphorus increased13.11.01.0160.031323%Not Available
Contusion23.03.11.002; 24.07.06.001; 15.03.01.008; 12.01.06.001--
Calciphylaxis14.04.01.0120.002514%Not Available
Blood phosphorus abnormal13.11.01.0170.014457%Not Available
Hypoaesthesia oral17.02.06.021; 07.05.05.0030.014457%Not Available
Paraesthesia oral17.02.06.008; 07.05.03.0030.012047%Not Available
Hot flush24.03.01.005; 21.02.02.001; 08.01.03.0270.009638%
Cardiac disorder02.01.01.003--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Ill-defined disorder08.01.03.0490.001886%Not Available
Drug intolerance08.06.01.0130.028914%Not Available
Unevaluable event08.01.03.0510.016866%Not Available
Peripheral arterial occlusive disease24.04.03.0100.012047%Not Available
Blood parathyroid hormone abnormal13.10.07.0040.045780%Not Available
Blood parathyroid hormone decreased13.10.07.0010.040961%Not Available
The 5th Page    First    Pre   5    Total 5 Pages